XOMA - XOMA Corp Stock Price, Fair Value and News

$30.80+1.04 (+3.49%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

XOMA Price Action

Last 7 days

-4.6%

Last 30 days

-6.8%

Last 90 days

-13.0%

Trailing 12 Months

-2.7%

XOMA RSI Chart

XOMA Valuation

Market Cap

381.4M

Price/Earnings (Trailing)

17.62

Price/Sales (Trailing)

8.1

EV/EBITDA

-62.62

Price/Free Cashflow

69.74

XOMA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

XOMA Fundamentals

XOMA Revenue

Revenue (TTM)

47.1M

Rev. Growth (Yr)

29.93%

Rev. Growth (Qtr)

-28.78%

XOMA Earnings

Earnings (TTM)

21.6M

Earnings Growth (Yr)

181.49%

Earnings Growth (Qtr)

52.88%

XOMA Profitability

Operating Margin

99.73%

EBT Margin

-41.35%

Return on Equity

24.61%

Return on Assets

8.22%

Free Cashflow Yield

1.43%

XOMA Investor Care

Shares Dilution (1Y)

5.10%

Diluted EPS (TTM)

0.96

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	42.9M	45.0M	47.1M	0
2024	5.8M	15.2M	21.6M	28.5M
2023	3.4M	4.0M	4.4M	4.8M
2022	40.9M	41.0M	40.5M	6.0M
2021	31.6M	33.8M	36.0M	38.2M
2020	11.0M	10.5M	2.2M	29.4M
2019	13.0M	11.7M	19.6M	18.4M
2018	40.8M	29.0M	17.1M	5.3M
2017	17.3M	29.1M	40.9M	52.7M
2016	56.8M	54.7M	53.2M	5.6M
2015	18.1M	14.7M	11.6M	55.4M
2014	29.4M	28.2M	27.1M	18.9M
2013	33.4M	31.2M	30.3M	35.5M
2012	52.5M	45.2M	36.2M	33.8M
2011	43.3M	52.6M	57.9M	58.2M
2010	0	0	0	33.6M

Get all data in R, Python etc through our Historical Stock Data APIs

About XOMA Corp

XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.

CEO	Mr. Owen P. Hughes Jr.
WEBSITE	xoma.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	11

XOMA Corp Frequently Asked Questions

What is the ticker symbol for XOMA Corp? What does XOMA stand for in stocks?

XOMA is the stock ticker symbol of XOMA Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of XOMA Corp (XOMA)?

As of Wed Dec 03 2025, market cap of XOMA Corp is 381.4 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of XOMA stock?

You can check XOMA's fair value in chart for subscribers.

Is XOMA Corp a good stock to buy?

The fair value guage provides a quick view whether XOMA is over valued or under valued. Whether XOMA Corp is cheap or expensive depends on the assumptions which impact XOMA Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XOMA.

What is XOMA Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, XOMA's PE ratio (Price to Earnings) is 17.62 and Price to Sales (PS) ratio is 8.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XOMA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on XOMA Corp's stock?

In the past 10 years, XOMA Corp has provided 0.013 (multiply by 100 for percentage) rate of return.